Reader-supported. We may earn a commission when you use our partner links. How we’re funded
Our take
LaSara offers a useful choice of supply periods. Compare full package totals and the actual prescription, and resolve its inconsistent monthly label before enrollment.
What stands out
- Several supply periods published
- Subscription and non-subscription prices distinguished
- Free consultation advertised
What to weigh
- Week-based supply is not a calendar-month plan
- A separate monthly label conflicts
- Exact preparation and monitoring require confirmation
Start with the supply period
LaSara's sermorelin selector is organized around weeks. It lists a six-week subscription at $242, twelve weeks at $449 and eighteen weeks at $719. Separate non-subscription plans show $269 for six weeks and $499 for twelve weeks. Those full totals are a more dependable starting point than the monthly equivalents printed beside some choices.
A twelve-week supply covers 84 days, so it should not casually be labeled three calendar months. When comparing clinics, write down the exact duration, amount due and renewal interval for each. That keeps a convenient monthly shorthand from concealing a difference in supply. The right question is what medication and care the full payment buys for the period stated.
The longer subscription is not the lowest weekly rate
Using the published totals, the twelve-week subscription works out to about $37.42 per week, compared with about $40.33 for six weeks and $39.94 for eighteen weeks. These are our arithmetic comparisons, not additional advertised offers. They assume the packages can fairly be compared on supply and inclusions, which a prospective patient should confirm.
A separate sticky label on the same page describes $288 as a monthly subscription. We cannot reconcile that with the week-based selector, so we would obtain a current written quote rather than select whichever number appears most favorable. Ask whether every tier has the same preparation, quantity per week and included clinical services. A longer commitment needs a specific explanation if it does not improve the effective rate.
Use the consultation to narrow the question
LaSara advertises a free consultation, and its homepage describes a sequence involving a medical form, consultation, doctor approval and home delivery. That creates an opportunity to ask about the proposal before committing to a package. We would arrive with a clear description of the concern and an accurate list of current medicines and relevant health history.
Ask which parts of the evaluation occur during the free conversation and which require a paid clinical service or testing. Also ask whether a clinician can review existing laboratory results. The aim is not simply to establish eligibility, but to understand why this treatment is being considered, what alternatives deserve attention and what information could change the recommendation.
Keep standalone and combination offers separate
LaSara's peptide catalog includes separate combinations involving sermorelin, including listings paired with L-carnitine or methylene blue. Their presence should not change what a standalone sermorelin quote means. We would request an explanation and an itemized price for any additional product rather than treating a bundle as the natural next step.
Adding treatments can make it harder for a patient to understand which change is associated with a benefit or an unwanted effect. Ask the clinician how each proposed component serves the stated goal and how progress will be assessed. The catalog's broad reverse-aging language is marketing context, not a measurable personal outcome. A focused plan should still have a defined reason for treatment and a point for reassessment.
Confirm the preparation and the exit terms
The product page advertises the ability to pause or cancel, but that brief statement does not explain the financial outcome after a package has begun. Ask when the pharmacy order becomes committed, whether all supplies ship together and what happens to the unused part of a longer plan if care changes. A twelve- or eighteen-week purchase deserves a clear answer before payment.
We would also request the actual formulation, dispensing pharmacy, total medication quantity and handling instructions. The product title alone is not a complete prescription specification. If administration requires supplies or preparation, confirm that assistance is included. These details allow a fair comparison with another clinic whose headline price may cover a different amount of medication or a different degree of follow-up.
Where LaSara belongs on a shortlist
LaSara is relevant to someone who wants a consultation and several explicit supply lengths rather than a single undifferentiated monthly offer. The published package totals provide useful information, while the inconsistent monthly label and unresolved product details prevent a simple price ranking. We would use the twelve-week total as a question to discuss, not as a recommendation to prepay.
Our review is based on the public offer and does not report treatment experience, pharmacy testing or a completed consultation. The deciding factor should be the quality of the explanation received: one current price, one clearly specified preparation and an understandable monitoring and cancellation arrangement. Once those are documented, the different plan lengths become a meaningful choice instead of merely a collection of numbers.
Common questions
What is LaSara’s starting sermorelin price?
The reviewed selector shows $242 for a six-week subscription. It also lists $449 for twelve weeks and $719 for eighteen weeks; a separate $288 monthly label needs clarification.
Is twelve weeks the same as three months?
No. LaSara’s supply periods are stated in weeks. Compare the full amount and exact duration rather than assuming a calendar-month billing interval.
Are LaSara’s combination products part of this price?
No. Its catalog lists separate combinations involving sermorelin. Do not assume these are included in the standalone sermorelin package.
Explore LaSara Medical Group
See the current offer and decide whether you want to start a consultation.
Visit LaSara Medical GroupReader-supported. We may earn a commission when you use our partner links. How we’re funded
Sources & further reading
Provider prices and terms may change.